SecBot SecBot
144 ·Filed Oct 13, 2026

BIOF

BLUE BIOFUELS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed13d 14h ago SEC0001493152-26-046781
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for actual sale execution on Form 4; the small dollar amount relative to market cap suggests this is a routine liquidity event by a director, not a signal of deteriorating fundamentals.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
BIOF ▼ -1.96% at T+5d
NEUTRAL call -1.96% · α vs SPY -0.81% · entry $0.1020 → $0.1000
Next anchor: T+20d in 14d
Latest observation: T+8 +2.33% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
0.00%
call 0.00% · α +1.08%
$0.1020
settled 13d ago
T+5d
-1.96%
call -1.96% · α -0.81%
$0.1000
settled 7d ago
T+20d
Pending
in 14d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Director Chris J. Kneppers filed a Form 144 notice of intent to sell 908,355 shares of Blue Biofuels, Inc. common stock, with an estimated aggregate market value of approximately $90,836 (based on a $0.10/share price). The shares were acquired in a private placement on 12/16/2019. The filing signals insider intent to sell, but the relatively small dollar amount and the director role (not CEO/CFO) suggest limited material impact.

Key Facts

  • Director Chris J. Kneppers filed a Form 144 to sell 908,355 shares of common stock.
  • Estimated aggregate market value of the sale is approximately $90,836 (based on $0.10/share).
  • Shares were acquired in a private placement on December 16, 2019.
  • The sale is planned to occur on or after October 15, 2026, on the OTCQB market.
  • The filing is an advance notice of intent to sell; the actual sale may not occur.

Financial Impact

Approximately $90,836 based on 908,355 shares at $0.10/share.

dilution

Risk Factors

  • Insider selling, even if small, may be perceived negatively by retail investors.
  • The company's low share price and OTCQB listing indicate potential liquidity and volatility risks.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001493152-26-046781
Document: 0001493152-26-046781-index.html0001493152-26-046781
Document: 0001493152-26-046781.txt0001493152-26-046781
2 reports for BIOF
Performance horizon
Filters
Rows
Reports for BIOF — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
144
NEUTRAL ★ 2/10
$0.1020awaiting T+20—$0.1150 (+12.75%)
Jun 8, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$0.1190 $0.1195▲ +0.42%▼ −0.97%$0.1150 (−3.36%)
Showing 2 of 2

US Market Status

Market Closed — Opens in 5h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026